The Impact of Charge Displays on Inpatient Laboratory Test Ordering

Health Behavior Clinical Trial

Official title:

The Impact of Charge Displays on Inpatient Laboratory Test Ordering

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02355496
• Other study ID #: 821783
• Status: Completed
• Phase: N/A
• First received: January 30, 2015
• Last updated: May 1, 2017
• Start date: April 2015
• Est. completion date: April 2016

Study information

• Verified date: May 2017
• Source: University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a clinical trial to evaluate the impact of presenting medicare fee data for inpatient laboratory tests in the electronic health record on provider ordering behavior at a tertiary care hospital.

Description:

This study is a clinical trial to determine the impact on inpatient laboratory test ordering of presenting providers with medicare fee data at the time of order entry. We will randomly assign 60 laboratory tests to an active arm (medicare fee data displayed) or to a control arm (medicare fee data not displayed). The primary outcome will be the change in the ratio of tests ordered per patient day over 12 months by study group (intervention vs. control).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 98529
• Est. completion date: April 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Exclusion Criteria:

Related Conditions & MeSH terms

• Health Behavior

Intervention

Other:
• Displaying medicare fee data
Using the computerized order entry system to make medicare fee data for a randomly selected inpatient laboratory tests transparent to providers at the time of order entry.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Pennsylvania

References & Publications (1)

Sedrak MS, Myers JS, Small DS, Nachamkin I, Ziemba JB, Murray D, Kurtzman GW, Zhu J, Wang W, Mincarelli D, Danoski D, Wells BP, Berns JS, Brennan PJ, Hanson CW, Dine CJ, Patel MS. Effect of a Price Transparency Intervention in the Electronic Health Record — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The ratio of tests ordered per patient-day	Number of tests ordered	12 months
Secondary	The total associated fees of tests ordered per patient-day	Associated costs of test	12 months

External Links

•   Publication in JAMA Internal Medicine